Citation

Prochazka H, Sjögren M, Agren H. J. Affect. Disord. 2000; 57(1-3): 201-208.

Affiliation

Institute of Clinical Neuroscience, Department of Psychiatry, Göteborg University, Sahlgrenska University Hospital/Mölndal, SE-431 80, Mölndal, Sweden.

Copyright

(Copyright © 2000, Elsevier Publishing)

DOI

unavailable

PMID

10708832

Abstract

BACKGROUND: Fenfluramine (d-FEN) has been used as a serotonin challenge agent to assess central serotonin availability. Blunted serum prolactin (PRL) response to d-FEN has been reported in depressed patients, in suicide-prone patients, and in patients with aggression and personality disorders. We have analyzed suicidality in relation to central serotonergic events by comparing the PRL response to d-FEN in chronically depressed patients with and without suicide attempts and in healthy volunteers. METHODS: In 56 inpatients (10 patients with and 46 without suicide attempts) with at least 2 years of treatment-refractory depression (TRD) (DSM-IV) and a reference group of 30 healthy adults, the PRL response after an oral dose of 30 mg d-FEN was followed for 5 h. RESULTS: Controlling for group differences in age, sex, and weight, the PRL response to d-FEN did not differ significantly between the three groups. Far from confirming the hypothesis of a blunted PRL response in depressed patients, our results suggest: (1) that duration and treatment resistance of depression may affect the PRL secretion, and (2) that TRD and major depression may differ in biological relationship to suicidal behavior. LIMITATIONS: The findings require corroboration in larger and more closely matched study populations. The fenfluramine concentration was not analyzed in blood. CONCLUSIONS: PRL responses to d-FEN challenge did not differ between TRD patients with and without suicidality and the healthy reference group. Chronicity/treatment refractoriness per se may be related to a serotonergic mechanism.

Language: en